August 2021 FDA Recall Carbamazepine by The Harvard Drug Group
D-0807-2021 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by The Harvard Drug Group on August 6, 2021 for the product Carbamazepine. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed in NC and the recall is currently terminated.

Recall Number: D-0807-2021

Reason for Recall
Failed Dissolution Specifications
Initiated
08-06-2021
Reported
09-29-2021
Quantity
4 Cartons of 100 count each

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group
Carbamazepine 200mg Tablets, USP, 200 mg, 100 Count Unit Dose Cartons, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd., Bharuch-392130, India; Manufactured for: Torrent Pharma, Inc., Basking Ridge, NJ 07920; Distributed by: MAJOR PHARMACEUTICALS, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC 0904-6172-61

Batch or Lot Expiration Information

Lot# Lot R01562; Exp. 10/2022